Drug Shortage Report for TEVA-TELMISARTAN
Report ID | 67225 |
Drug Identification Number | 02320185 |
Brand name | TEVA-TELMISARTAN |
Common or Proper name | TELMISARTAN |
Company Name | TEVA CANADA LIMITED |
Market Status | MARKETED |
Active Ingredient(s) | TELMISARTAN |
Strength(s) | 80MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 100 |
ATC code | C09CA |
ATC description | ANGIOTENSIN II ANTAGONISTS, PLAIN |
Reason for shortage | Requirements related to complying with good manufacturing practices. |
Anticipated start date | |
Actual start date | 2018-11-20 |
Estimated end date | 2020-06-30 |
Actual end date | 2020-05-07 |
Shortage status | Resolved |
Updated date | 2020-05-08 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v35 | 2020-05-08 | French | Compare |
v34 | 2020-05-08 | English | Compare |
v33 | 2020-05-01 | French | Compare |
v32 | 2020-05-01 | English | Compare |
v31 | 2020-04-16 | French | Compare |
v30 | 2020-04-16 | English | Compare |
v29 | 2020-04-02 | French | Compare |
v28 | 2020-04-02 | English | Compare |
v27 | 2020-02-13 | French | Compare |
v26 | 2020-02-13 | English | Compare |
v25 | 2020-01-09 | French | Compare |
v24 | 2020-01-09 | English | Compare |
v23 | 2019-12-12 | French | Compare |
v22 | 2019-12-12 | English | Compare |
v21 | 2019-10-31 | French | Compare |
v20 | 2019-10-31 | English | Compare |
v19 | 2019-10-03 | French | Compare |
v18 | 2019-10-03 | English | Compare |
v17 | 2019-08-22 | French | Compare |
v16 | 2019-08-22 | English | Compare |